Skip to main navigation Skip to search Skip to main content

Patient, Disease, and Drug-Related Risk Factors Associated with Pheny-toin-Induced Cutaneous Adverse Drug Reactions in South Indian Epileptic Patients-A Prospective Case-Control Study

  • Shobana John
  • , Bhutorn Canyuk
  • , T. C.Vijay Anand
  • , Chonlaphat Sukasem
  • , Sutthiporn Pat-Tharachayakul
  • Prince of Songkla University
  • Meenakshi Mission Hospital and Research Centre

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Background: Phenytoin is the most commonly reported aromatic Anti-Epileptic Drug (AED) to cause Cutaneous Adverse Drug Reactions (CADRs). Cutaneous adverse drug reactions may be immune or non-immune mediated. It has been observed that predisposition is multifactorial and that gene mutations alone cannot be the cause. Objectives: In this study, we investigated the patient, disease, and drug-related risk factors associated with phenytoin-induced cutaneous adverse drug reactions in South Indian epileptic patients. Methods: This study was conducted as a single-center prospective case-control study over a period of 13 months. The Fisher’s exact test and multivariate binary logistic regression analysis were used to test the association of single and multiple variables, respectively. Results: This study comprised 26 patients with phenytoin-induced cutaneous adverse drug reactions (PHT-CARDs) and 32 phenytoin-tolerant controls with a mean age of 40.60±18.15 and 36.21±14.71 years, respectively. Among 26 phenytoin-induced cutaneous adverse drug reactions, 76.92% cases were mild-moderate reactions and 23.07% were severe. The onset latency period of these reactions ranged from 7-42 days. The multivariate analysis showed that multiple AEDs (OR =18.62, 95% CI 4.28-80.87, p=< .001) and comorbidities (OR= 5.98, 95% CI 1.33-26.78, p=.01) are risk factors for PHT-CADRs. PHT-SCARs were shown to be associated with previous allergy history (OR= 31, % CI 2.40-398.8, p=.008). Conclusion: The risk factors found to be associated with CARDs in South Indian Epileptic patients are multiple AEDs, comorbidities, and past allergic history. Therefore, physicians and other associated health care professionals should closely monitor the patients when phenytoin is em-ployed.

Original languageEnglish
Pages (from-to)241-249
Number of pages9
JournalCurrent Drug Safety
Volume17
Issue number3
DOIs
Publication statusPublished - Aug 2022

Keywords

  • AEDs
  • Cutaneous Adverse Drug Reactions (CADRs)
  • Phenytoin (PHT)
  • epileptic patients
  • gene mutations
  • risk factors

Fingerprint

Dive into the research topics of 'Patient, Disease, and Drug-Related Risk Factors Associated with Pheny-toin-Induced Cutaneous Adverse Drug Reactions in South Indian Epileptic Patients-A Prospective Case-Control Study'. Together they form a unique fingerprint.

Cite this